Digital Pathology Market by Product( ArtificiaI Intelligence, Scanner, Software, Storage), Type(Human, Veterinary), Application( Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User( Pharma, Academia, Hospitals ) - Global Forecast to 2
Description
Digital Pathology Market by Product( ArtificiaI Intelligence, Scanner, Software, Storage), Type(Human, Veterinary), Application( Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User( Pharma, Academia, Hospitals ) - Global Forecast to 2026
The global digital pathology market is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, rising incidence of cancer, and growing applications of digital pathology in drug development and companion diagnostics. On the other hand, the high costs of digital pathology systems are expected to restrain market growth to a certain extent.
“The scanners segment accounted for the largest share of the Digital Pathology market in 2020.”
Based on products, the digital pathology market has been segmented into scanners, software, and storage systems. The large share of the scanners segment can be attributed to the high price of scanners and the increasing adoption of digital pathology solutions.
“The human pathology segment accounted for the largest share of the Digital Pathology market in 2020
Based on type, the global digital pathology market is segmented into human pathology and veterinary pathology. The human pathology segment accounted for the largest share of the digital pathology market in 2020. This is due to the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories.
“The drug discovery, segment accounted for the largest share of the Digital Pathology market in 2020.”
Based on application, the digital pathology market is segmented into drug discovery, disease diagnosis, and training & education. The drug discovery segment accounted for the largest share of the digital pathology market in 2020. Growth in R&D expenditure fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is a major factor responsible for market growth.
“The pharmaceutical & biotechnology companies, segment accounted for the largest share of the Digital Pathology market in 2020.”
Based on end users, the global digital pathology market is segmented into pharmaceutical & biotechnology companies, hospitals & reference laboratories, and academic & research institutes. The pharmaceutical & biotechnology companies segment accounted for the largest share of the digital pathology market in 2020. The large share of this segment can be attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.
“The market in North America is projected to witness the highest growth rate during the forecast period (2021–2026).”
North America accounted for the largest share of the digital pathology market in 2020. The increasing prevalence of cancer, rising demand for quality diagnostics, the introduction of favorable reimbursement policies, and the implementation of favorable initiatives by the governments in the US and Canada are major factors driving the growth of the digital pathology market in North America.
A breakdown of the primary participants referred to for this report is provided below:
By Company Type (Supply-side): Tier 1: 29%, Tier 2: 37%, and Tier 3: 34%
By Company Type (Demand-side): Tier 1: 55%, Tier 2: 35%, and Tier 3: 10%
By Designation: C-level: 35%, Director-level: 25%, and Others: 40%
By Region: North America: 35%, Europe: 32%, Asia-Pacific: 22%, and RoW:11%
The major players in the Digital Pathology market include Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN, Inc. (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Aiforia Technologies Oy (Finland), Akoya Biosciences (US), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (US), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Inspirata, Inc. (US), PathAI (US), Proscia Inc. (US), Kanteron Systems (Spain), Mikroscan Technologies (US), Motic (US), and Paige (US).
Research Coverage:
The report analyzes the digital pathology market and aims at estimating the market size and future growth potential of this market based on various segments such as product, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.
This report provides insights into the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on the products and region.
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the digital pathology market.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of digital pathology solutions across regions.
Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital pathology market.
Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital pathology markets.
The global digital pathology market is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, rising incidence of cancer, and growing applications of digital pathology in drug development and companion diagnostics. On the other hand, the high costs of digital pathology systems are expected to restrain market growth to a certain extent.
“The scanners segment accounted for the largest share of the Digital Pathology market in 2020.”
Based on products, the digital pathology market has been segmented into scanners, software, and storage systems. The large share of the scanners segment can be attributed to the high price of scanners and the increasing adoption of digital pathology solutions.
“The human pathology segment accounted for the largest share of the Digital Pathology market in 2020
Based on type, the global digital pathology market is segmented into human pathology and veterinary pathology. The human pathology segment accounted for the largest share of the digital pathology market in 2020. This is due to the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories.
“The drug discovery, segment accounted for the largest share of the Digital Pathology market in 2020.”
Based on application, the digital pathology market is segmented into drug discovery, disease diagnosis, and training & education. The drug discovery segment accounted for the largest share of the digital pathology market in 2020. Growth in R&D expenditure fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is a major factor responsible for market growth.
“The pharmaceutical & biotechnology companies, segment accounted for the largest share of the Digital Pathology market in 2020.”
Based on end users, the global digital pathology market is segmented into pharmaceutical & biotechnology companies, hospitals & reference laboratories, and academic & research institutes. The pharmaceutical & biotechnology companies segment accounted for the largest share of the digital pathology market in 2020. The large share of this segment can be attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.
“The market in North America is projected to witness the highest growth rate during the forecast period (2021–2026).”
North America accounted for the largest share of the digital pathology market in 2020. The increasing prevalence of cancer, rising demand for quality diagnostics, the introduction of favorable reimbursement policies, and the implementation of favorable initiatives by the governments in the US and Canada are major factors driving the growth of the digital pathology market in North America.
A breakdown of the primary participants referred to for this report is provided below:
By Company Type (Supply-side): Tier 1: 29%, Tier 2: 37%, and Tier 3: 34%
By Company Type (Demand-side): Tier 1: 55%, Tier 2: 35%, and Tier 3: 10%
By Designation: C-level: 35%, Director-level: 25%, and Others: 40%
By Region: North America: 35%, Europe: 32%, Asia-Pacific: 22%, and RoW:11%
The major players in the Digital Pathology market include Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN, Inc. (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Aiforia Technologies Oy (Finland), Akoya Biosciences (US), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (US), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Inspirata, Inc. (US), PathAI (US), Proscia Inc. (US), Kanteron Systems (Spain), Mikroscan Technologies (US), Motic (US), and Paige (US).
Research Coverage:
The report analyzes the digital pathology market and aims at estimating the market size and future growth potential of this market based on various segments such as product, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.
This report provides insights into the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on the products and region.
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the digital pathology market.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of digital pathology solutions across regions.
Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital pathology market.
Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital pathology markets.
Table of Contents
242 Pages
- STUDY OBJECTIVES
- MARKET DEFINITION
- MARKET SCOPE
- CURRENCY
- LIMITATIONS
- STAKEHOLDERS
- SUMMARY OF CHANGES
- RESEARCH DATA
- MARKET SIZE ESTIMATION
- MARKET BREAKDOWN AND DATA TRIANGULATION
- MARKET SHARE ESTIMATION
- ASSUMPTIONS FOR THE STUDY
- RISK ASSESSMENT
- MARKET LIMITATIONS
- EXECUTIVE SUMMARY
- DIGITAL PATHOLOGY MARKET OVERVIEW
- NORTH AMERICA: DIGITAL PATHOLOGY SOLUTIONS MARKET, BY END USER & COUNTRY (2020)
- DIGITAL PATHOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- REGIONAL MIX: DIGITAL PATHOLOGY MARKET (2021-2026)
- DIGITAL PATHOLOGY MARKET: DEVELOPING VS. DEVELOPED MARKETS
- INTRODUCTION
- MARKET DYNAMICS
- COVID-19 IMPACT ANALYSIS
- ECOSYSTEM MARKET MAP
- TRENDS IN AVERAGE SELLING PRICE
- IMPACT OF THE NEW IVD REGULATION ON DIFFERENT MARKETS
- TECHNOLOGY ANALYSIS
- PATENT ANALYSIS
- INTRODUCTION
- SCANNERS
- SOFTWARE
- COMMUNICATION SYSTEMS
- STORAGE SYSTEMS
- INTRODUCTION
- HUMAN PATHOLOGY
- VETERINARY PATHOLOGY
- INTRODUCTION
- DRUG DISCOVERY
- DISEASE DIAGNOSIS
- TELECONSULTATION
- TRAINING & EDUCATION
- INTRODUCTION
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- HOSPITALS AND REFERENCE LABORATORIES
- ACADEMIC & RESEARCH INSTITUTES
- INTRODUCTION
- NORTH AMERICA
- EUROPE
- ASIA PACIFIC (APAC)
- LATIN AMERICA
- MIDDLE EAST & AFRICA
- OVERVIEW
- KEY PLAYER STRATEGIES/RIGHT-TO-WIN
- REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
- COMPETITIVE BENCHMARKING
- COMPETITIVE LEADERSHIP MAPPING
- COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES
- MARKET SHARE ANALYSIS
- COMPETITIVE SCENARIO
- KEY PLAYERS
- OTHER PLAYERS
- DISCUSSION GUIDE
- KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- AVAILABLE CUSTOMIZATIONS
- RELATED REPORTS
- AUTHOR DETAILS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
